CD226 and systemic lupus erythematosus: Across all B cell subsets, CD226+ SM B cells and CD226+ plasmablasts were associated with disease activity of SLE, consistent with the reports that showed SM B cells and plasmablasts increased in SLE patients and were associated with disease activity (36–39).